Alpuente, Alicia http://orcid.org/0000-0001-5296-9401
Gallardo, Victor J. http://orcid.org/0000-0002-3042-2007
Asskour, Laila
Caronna, Edoardo http://orcid.org/0000-0001-5525-0267
Torres-Ferrus, Marta http://orcid.org/0000-0003-2856-4134
Pozo-Rosich, Patricia http://orcid.org/0000-0003-0796-4702
Article History
Received: 22 March 2024
Accepted: 15 April 2024
First Online: 18 April 2024
Declarations
:
: In relation with this paper the authors have nothing to disclose. AA has received honoraria as speaker from Pfizer, Lundbeck, AbbVie, Novartis and Eli Lilly. VJG has received honoraria as speaker for Eli Lilly and Novartis. LA has nothing to disclose. EC has received honoraria as consultant or speaker for Novartis, Chiesi and Medlink. MT-F has received honoraria as a consultant or speaker for Allergan-Abbvie, Almirall, Chiesi, Eli Lilly, Novartis, Teva and Medlink. In the last five years, PPR has received honoraria as a consultant and speaker for: Abbvie, Amgen, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis and Teva. Her research group has received research grants from AbbVie, Novartis and Teva; and has received funding for clinical trials from Alder, Abbvie, Amgen, Electrocore, Eli Lilly, Lundbeck, Novartis and Teva. She is the Honorary Secretary of the International Headache Society. She is in the editorial board of Neurologia, and Revista de Neurologia, associate editor for Cephalalgia, Headache and The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee and Scientific Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of ExternalRef removed. PP-R does not own stocks from any pharmaceutical company.
: The authors declare no competing interests.